Published Medical Papers

There is a growing body of evidence to support the use of SurgihoneyRO. It has been shown to kill superbugs in the laboratory and heal chronic wounds.

Laboratory tests compared it to other wound care products and clinical studies demonstrated positive outcomes for a variety of acute and chronic wounds.

Most of the published medical papers and posters can be viewed on this website and all are available on request at info@reactiveoxygen.com

British Journal of Healthcare Management, prudent antibiotic stewardship in wound care management – Volume 24, Issue 4, April 2018
20th April 2018

Read Article »

Journal of Clinical Pathology, antimicrobial activity of a novel, engineered honey against non-typeable Haemophilus influenzae biofilms: an in vitro study
24th February 2018

Please note this medical use is outside of the indications or conditions for which SurgihoneyRO is currently accredited as a topical wound gel (antimicrobial)

Read Article »

Poster Wounds UK – Healing challenging wounds with SurgihoneyRO – a novel antimicrobial wound gel
15th November 2017

Download PDF »

Poster Wounds UK – Use of an antimicrobial engineered honey wound gel to eradicate pre-formed biofilms of important wound pathogens: an in vitro study
15th November 2017

Download PDF »

International Journal of Antimicrobial Agents- Reactive Oxygen therapy: a novel antimicrobial
7th September 2017

Read Article »

International Journal of Surgery Protocols – Impact of Surgihoney Reactive Oxygen on Surgical Site Infection (SSI) after complex Abdominal Wall Reconstruction (AWR) of Grade 3 and Grade 4 Ventral Hernias: A Single Arm Study
14th August 2017

Please note this medical use is outside of the indications or conditions for which SurgihoneyRO is currently accredited as a topical wound gel (antimicrobial)

Read Article »

Journal of Wound Care – Use of an engineered honey to eradicate preformed biofilms of important wound pathogens: an in vitro study
14th August 2017

The engineered honey (SurgihoneyRO) was tested against 16 clinically relevant wound pathogens for its impacts on biofilm seeding and biomass FD Haltead, M A Webber, B A Oppenheim

Read Article »

International Journal of Molecular Sciences: Review – Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What is the Role of Antibiotics?
8th August 2017

Read Article »

Wounds UK – Reactive oxygen species in the management of wounds
3rd July 2017

Read Article »

Poster – Development of an engineered honey (SurgihoneyRO) as a novel, topical treatment
7th June 2017

Poster presentation to Royal College of Surgeons England and NAMRIP (Network against antimicrobial resistance and infection prevention) at the University of Southampton, June 2017

Download PDF »

Current Opinion Review – Reactive Oxygen therapy: a novel therapy in soft tissue infection
9th March 2017

Read Article »

Royal College of Surgeons bulletin – Surgery and honey
3rd March 2017

Read Article »

Journal of Global Antimicrobial Resistance – Reactive Oxygen: a novel antimicrobial mechanism for targeting biofilm-associated infections
20th February 2017

Read Article »

Journal of Global Antimicrobial Resistance – Hot topics in Reactive Oxygen therapy: antimicrobial & immunological mechanisms, safety & clinical applications
20th February 2017

Read Article »

International Journal of Antimicrobial Agents – Prosthetic joints: shining light on challenging blind spots
8th December 2016

A collaborative paper by Kordo Saeed et al on behalf of the International Society of Chemotherapy on joint replacement and prosthetic joint infection. It reviews the literature and discusses the role of SurgihoneyRO as an entirely novel solution to controlling/erradicating bacteria by slow, sustained release of hydrogen peroxide and other oxygen radicals. “SHRO is rapidly active in…

Read More »

1 2 3